Immunome Options Price 9.4 Percent Move Ahead of Earnings

By EC Assets · Published 6 November 2026

Options trading activity indicates Immunome Inc. shares could experience a 9.4% price swing following its upcoming quarterly financial results. The biotechnology company is scheduled to report earnings on Nov. 13. Shares of Immunome traded up 1.93% heading into the release. The projected volatility follows significant investor activity in the equity. A biotechnology-focused investment fund added $12 million to its position in Immunome as the stock surged 120%. Broader equity markets have experienced sharp volatility across key technology and semiconductor segments. Asian chipmakers including SK Hynix, Samsung, Softbank, and TSMC tumbled following a sell-off on the Nasdaq. Meanwhile, shares of Nvidia and Advanced Micro Devices rebounded as investors assessed whether an intense sell-off in artificial intelligence stocks had concluded. Bank of America strategist Michael Hartnett noted that despite steep equity market drops, three conditions across other asset markets must align before investors should rush back into equities. Market participants also faced pressure as data center buildouts for artificial intelligence shifted into a war of attrition following midterm developments. Immunome will report its earnings on Nov. 13, when market participants will monitor whether the projected 9.4% options-implied price movement materializes. This article is intended for informational purposes only. It does not constitute investment advice.